DR. CHRISTOPHER E CAMPBELL, OD
Optometry at Fowler Ave, Tampa, FL

License number
Florida FLOPC3331
Category
Optometry
Type
Optometrist
Address
Address 2
2201B E Fowler Ave, Tampa, FL 33612
305 Bahia Vista Dr, Belleair Beach, FL 33785
Phone
(813) 972-1573
(813) 632-0563 (Fax)
(727) 215-4550
(813) 632-0543 (Fax)

Professional information

Christopher Campbell Photo 1

Vp Of Engineering At Bay Area Innovations

Position:
VP of Engineering at Bay Area Innovations
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Mechanical or Industrial Engineering
Work:
Bay Area Innovations - Tampa/St. Petersburg, Florida Area since Jun 2012 - VP of Engineering Marsh Bellofram - Tampa/St. Petersburg, Florida Area Jun 2011 - Jun 2012 - Mechanical Engineer, King-Gage division King Engineering corp Feb 2008 - Jul 2011 - Engineering/Project Manger Outback Steakhouse May 2003 - Feb 2008 - Head Server, Trainer
Education:
University of South Florida 2012 - 2014
Master of Engineering Management, Engineering/Industrial Management
University of Michigan-Dearborn 2008 - 2011
BSME, Mechanical Engineering
Skills:
Product Development, Manufacturing, Finite Element Analysis, Project Management, Design for Manufacturing, Strategic Planning, Team Building, Business Strategy, Data Acquisition, GD&T, Machining, CFD, Product Design


Christopher E Campbell Photo 2

Christopher E Campbell, Tampa FL - OD (Doctor of Optometry)

Specialties:
Optometry
Address:
2201B E Fowler Ave, Tampa 33612
(813) 972-1573 (Phone), (813) 632-0563 (Fax)
Languages:
English


Christopher Campbell Photo 3

Method And Composition Using A Dual Specificity Protein Tyrosine Phosphatase As An Antimalarial Drug Target

US Patent:
2012007, Mar 29, 2012
Filed:
Sep 20, 2011
Appl. No.:
13/237525
Inventors:
John H. Adams - Tampa FL, US
Bharath Balu - Harrisonburg VA, US
Steven P. Maher - Tampa FL, US
Christopher O. Campbell - Tampa FL, US
Roman Manetsch - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61K 31/5377, A61K 31/122, A61K 31/7088, A61K 31/403, A61P 33/06, A61K 31/655, A61K 31/4365
US Classification:
514 44 R, 5142352, 514150, 514681, 514301, 514411
Abstract:
Phosphotyrosine phosphatase (PTP) encoded by PF13_0027 is a desirable drug target for the human malaria parasite . This PTP is critical for intraerythrocytic parasite development and invasion of erythrocytes by malaria merozoites. Mutation of the PF13_0027 gene or blocking expression of PTP function to create a PTP-null parasite severely attenuates the malaria parasite's ability to survive, making the PTP-null parasite suitable as an attenuated blood-stage parasite vaccine.